Bradley Campbell

Bradley Campbell serves as President and Chief Executive Officer at Amicus Therapeutics. Amicus Therapeutics operates in the research sector with approximately 620.0 employees. The company is headquartered in Princeton, New Jersey. Amicus Therapeutics generates annual revenue of 528299000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • We have verified contacts for 3 executives at Amicus Therapeutics.
• • 1,484 executive contacts are available in New Jersey.
• • Our database includes 201,469 c suite-level executives.

Salesforce Amazon SES Mimecast Outlook Amazon AWS Drupal Taleo OneTrust React Active Campaign Google Font API Twitter Advertising Facebook Custom Audiences Facebook Login (Connect) Google Analytics Vimeo Mobile Friendly New Relic Linkedin Marketing Solutions Akamai RUM Facebook Widget WordPress.org Apache MouseFlow Google Tag Manager IoT Remote Micro

healthcare biotechnology life sciences biotechnology: pharmaceutical preparations health care biotechnology research amicus therapeutics rare diseases therapies fabry disease pompe disease batten disease galafold migalastat pombiliti opfolda cipaglucosidase alfa-atga clinical trials human genetic diseases expanded access patient advocacy healthcare professionals medical affairs esg reporting corporate governance investor relations patients therapeutic innovation patient support drug development pharmaceuticals orphan diseases metabolic diseases global healthcare clinical research healthcare partnerships medical ethics patient access rare disease community medical resources biological therapies healthcare equity patient stories health outcomes medical compliance pharma collaboration biotech solutions shareholders fda approval patient safety therapeutic effectiveness research & development innovation in medicine public health patient-centered care genetic disorders pharmacological chaperones small molecule drugs patient-centric approach innovative therapies gene therapy patient access programs research excellence global reach niche market unmet medical needs enzyme replacement therapy advanced therapies healthcare collaboration transformative treatments biopharmaceutical sector clinical development pipeline patient experience precision medicine metabolic disorders patient communities rare genetic diseases commercial presence healthcare providers patient demographics revenue growth financial performance scientific presentations health wellness & fitness hospital & health care medical

SM

Sebastien Martel Chief Business Officer - Member of the Executive Committee at Amicus Therapeutics

PO

Pat Osullivan Chief Technical Operations Officer at Amicus Therapeutics

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

How can I contact Bradley Campbell?

Bradley Campbell's verified email address is available on MessageCEO. They currently work at Amicus Therapeutics. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Bradley Campbell lead?

Bradley Campbell is President and Chief Executive Officer at Amicus Therapeutics, a company in the research sector with 620.0 employees. The company is based in Princeton, New Jersey.

What industry is Bradley Campbell in?

Bradley Campbell works in the research industry as President and Chief Executive Officer at Amicus Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Bradley Campbell's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Bradley Campbell's profile is kept up-to-date with the latest available information.

Last updated: April 9, 2026